US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalI
INCY
Incyte Corp
66.43
0.26+0.39%After Hours: 66.43 0.00 0.00%16:32 10/17 EDT
OPEN/PREV CLOSE65.99/66.17
TODAY RANGE65.44-66.49
VOL1.36M
MARKET CAP12.79B
52 WEEK RANGE50.27-70.36
AVG VOL (3M)1.92M
% TURNOVER0.70%
TURNOVER--
P/E (TTM)187.81
% RANGE1.59%
EPS(TTM)0.3537
P/E(FORWARD)45.75
P/B4.246
BVPS15.64
DIVIDEND--
P/S4.032
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.50B
SHARES OUTSTANDING192.60M
NEXT EARNINGS--
FREE FLOAT188.22M
LOT SIZE1
EX-DIV DATE09/01/2000
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Innate Pharma appoints Jonathan Dickinson as CEO
Benzinga·10/10 19:30
A Look Into Incyte Inc's Price Over Earnings
Dow Jones·10/10 15:32
Incyte Price Target Cut to $62.00/Share From $63.00 by Wells Fargo
Dow Jones·10/10 15:32
Incyte Is Maintained at Equal-Weight by Wells Fargo
Benzinga·10/10 15:22
Wells Fargo Maintains Equal-Weight on Incyte, Lowers Price Target to $62
Reuters·10/10 10:29
INCYTE CORPORATION <INCY.O>: WELLS FARGO CUTS TARGET PRICE TO $62 FROM $63
Reuters·10/10 06:39
U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku
NASDAQ·10/08 15:40
GMAB or INCY: Which Is the Better Value Stock Right Now?
NASDAQ·10/08 14:51
SPDR S&P Biotech ETF Experiences Big Outflow
Dow Jones·10/08 12:04
Press Release: Incyte to Report Third Quarter Financial Results
Benzinga·10/01 13:00
Assessing Incyte: Insights From 11 Financial Analysts
Dow Jones·10/01 10:16
Incyte Initiated at Outperform by Wolfe Research
Same Industry
Name/Symbol
Change%
Price